Integra Lifesciences Holdings (IART) Net Cash Flow Growth (5y) (2014 - 2026)
Integra Lifesciences Holdings (IART) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Integra Lifesciences Holdings | 1.50 Bn | 1.24 Bn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.59% |
| Dec 31, 2025 | -54.70% |
| Sep 30, 2025 | -12.79% |
| Jun 30, 2025 | -124.53% |
| Mar 31, 2025 | -15.70% |
| Dec 31, 2024 | 37.60% |
| Sep 30, 2024 | -17.24% |
| Jun 30, 2024 | -87.15% |
| Mar 31, 2024 | 75.83% |
| Dec 31, 2023 | 39.58% |
| Sep 30, 2023 | -27.17% |
| Jun 30, 2023 | 8.00% |
| Mar 31, 2023 | -72.42% |
| Dec 31, 2022 | 26.24% |
| Sep 30, 2022 | -25.30% |
| Jun 30, 2022 | 14.63% |
| Mar 31, 2022 | -47.43% |
| Dec 31, 2021 | 120.21% |
| Sep 30, 2021 | 30.28% |
| Jun 30, 2021 | -26.83% |